51 related articles for article (PubMed ID: 31746425)
1. A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Bai Y; Li LD; Li J; Chen RF; Yu HL; Sun HF; Wang JY; Lu X
Int J Oncol; 2020 Jan; 56(1):301-314. PubMed ID: 31746425
[TBL] [Abstract][Full Text] [Related]
2. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT.
You S; Han X; Xu Y; Sui L; Song K; Yao Q
Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
[TBL] [Abstract][Full Text] [Related]
3. The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations.
Zhao E; Gao K; Xiong J; Liu Z; Chen Y; Yi L
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17269-17284. PubMed ID: 37814066
[TBL] [Abstract][Full Text] [Related]
4. TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer.
Lecker LSM; Berlato C; Maniati E; Delaine-Smith R; Pearce OMT; Heath O; Nichols SJ; Trevisan C; Novak M; McDermott J; Brenton JD; Cutillas PR; Rajeeve V; Hennino A; Drapkin R; Loessner D; Balkwill FR
Cancer Res; 2021 Nov; 81(22):5706-5719. PubMed ID: 34561272
[TBL] [Abstract][Full Text] [Related]
5. Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition.
Prasanphanich AF; Arencibia CA; Kemp ML
Free Radic Biol Med; 2014 Nov; 76():1-13. PubMed ID: 25088330
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-based genome-wide screening for metastasis ability identifies FCGR1A regulating the metastatic process of ovarian cancer by targeting LSP1.
Qi Y; Zhu W; Mo K; Jiang H
J Cancer Res Clin Oncol; 2024 Jun; 150(6):306. PubMed ID: 38879666
[TBL] [Abstract][Full Text] [Related]
7. TRIM8 promotes ovarian cancer proliferation and migration by targeting VDAC2 for ubiquitination and degradation.
Wu F; Xu J; Jin X; Zhu Y; Gao W; Liu M; Zhang Y; Qian W; Huang X; Zhao D; Feng G; Hou S; Xi X
Cancer Med; 2024 Jun; 13(11):e7396. PubMed ID: 38881325
[TBL] [Abstract][Full Text] [Related]
8. Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model.
Price JC; Azizi E; Naiche LA; Parvani JG; Shukla P; Kim S; Slack-Davis JK; Pe'er D; Kitajewski JK
PLoS One; 2020; 15(6):e0233962. PubMed ID: 32525899
[TBL] [Abstract][Full Text] [Related]
9. FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas.
Raman P; Purwin T; Pestell R; Tozeren A
Cancer Inform; 2015; 14():113-9. PubMed ID: 26494976
[TBL] [Abstract][Full Text] [Related]
10. β-catenin/TCF4-induced SCUBE3 upregulation promotes ovarian cancer development via HIF-1 signaling pathway.
Shen J; Ma X; Wei Z; Qian Q; Jing A; Ding Y; Geng T; Qin J; Ma L; Chen Y; Ji J; Liu B; Huang J
Mol Cell Endocrinol; 2024 Mar; 582():112127. PubMed ID: 38109990
[TBL] [Abstract][Full Text] [Related]
11. [Retracted] ATP‑binding cassette transporter A7 accelerates epithelial‑to‑mesenchymal transition in ovarian cancer cells by upregulating the transforming growth factor‑β signaling pathway.
Liu X; Li Q; Zhou J; Zhang S
Oncol Lett; 2024 Aug; 28(2):353. PubMed ID: 38872857
[TBL] [Abstract][Full Text] [Related]
12. Correction to: Dominant‑negative transforming growth factor‑β receptor‑armoured mesothelin‑targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer.
Li K; Xu J; Wang J; Lu C; Dai Y; Dai Q; Zhang W; Xu C; Wu S; Kang Y
Cancer Immunol Immunother; 2024 Apr; 73(6):105. PubMed ID: 38634982
[No Abstract] [Full Text] [Related]
13. Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancer.
Bai Y; Li L; Li J; Lu X
Heliyon; 2024 May; 10(9):e30727. PubMed ID: 38774095
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders.
Juárez-Barber E; Corachán A; Carbajo-García MC; Faus A; Vidal C; Giles J; Pellicer A; Cervelló I; Ferrero H
Reprod Biol Endocrinol; 2024 Jan; 22(1):10. PubMed ID: 38195505
[TBL] [Abstract][Full Text] [Related]
15. miR-1180 Targets FXYD5 to Regulate Pancreatic Cancer Cells Migration and Invasion.
Xie H; Li J; Lu M; Zhang R; Mao H
Mol Biotechnol; 2023 Dec; ():. PubMed ID: 38155284
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of exosomes secreted during the epithelial-mesenchymal transition and potential biomarkers of mesenchymal high-grade serous ovarian carcinoma.
Ferreira GA; Thomé CH; Izumi C; Grassi ML; Lanfredi GP; Smolka M; Faça VM; Candido Dos Reis FJ
J Ovarian Res; 2023 Nov; 16(1):232. PubMed ID: 38031074
[TBL] [Abstract][Full Text] [Related]
17. Multi-Organ Nutrigenomic Effects of Dietary Grapes in a Mouse Model.
Dave A; Park EJ; Pezzuto JM
Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891900
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell Transcriptome Profiling of Pancreatic Islets From Early Diabetic Mice Identifies Anxa10 for Ca2+ Allostasis Toward β-Cell Failure.
Motomura K; Matsuzaka T; Shichino S; Ogawa T; Pan H; Nakajima T; Asano Y; Okayama T; Takeuchi T; Ohno H; Han SI; Miyamoto T; Takeuchi Y; Sekiya M; Sone H; Yahagi N; Nakagawa Y; Oda T; Ueha S; Ikeo K; Ogura A; Matsushima K; Shimano H
Diabetes; 2024 Jan; 73(1):75-92. PubMed ID: 37871012
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
